Fall Convention 2025

jointly hosted by the EAA and EURORDIS

'EU HTA - Procedural Insights & First Learnings'

at Université Paris Cité (Villemin Site)

on November 6/7, 2025

Click here to sign up and join the discussions

(on-site & virtual participation possible, restrictions apply).

Agenda*

Thursday, Nov 6th: Public Session

15:30 - Introduction & Setting the Scene (J-F. Bergmann, F. Houÿez)

15:50 - Welcome Message (MEP V. Andriukaitis)

16:00 - Plenary Session Part 1: Procedural Insights

 Impulse presentations by Leslie Pibouleau (DG Santé), Pierre Cochat (HAS), Marcus Guardian (BCCH), Michael   Berntgen (EMA), François Houÿez (EURORDIS), Bernhard Wörmann (DGHO), James Ryan (EFPIA)

 followed by Plenary Discussion & Coffee Break

17:45 - Plenary Session Part 2: Roundtable on EU HTA KPI

 with Elaine Julian (EAA), Antonella Cardone (CPE), Étienne Lengliné (EHA), Frank-Ulrich Fricke (TH Nürnberg), Maria João Garcia (Roche)

18:45 SUSTAIN HTA - Sharing Status & Insights (Wim Goettsch, Utrecht University)

Friday, Nov 7th: Working Session

08:30 - Welcome (M. Pavlovic, F. Houÿez)

08:35 - Involvement of Experts and HTA Bodies

 Oncolocy Perspective (Jean-Yves Blay, Centre Léon Bérard Lyon)

 Update from the Coordination Subgroup JCA (Camille Thomassin, HAS & CG)

 National Perspective Poland (Anna Kowalczuk, AOTMiT)

 National Trade Association Insights (Laurent Petit, LEEM)

09:15 - Break-Out Sessions on Measuring KPIs for EU HTA

 from Patient/ Clinician/ HTD/ MS Perspective

11:30 - Report from Break-Out Groups & Final Panel Discussion

12:30 - End of Fall Convention

* Agenda details and times are subject to change.

The expert panel  includes

Leslie Pibouleau (DG Santé), Marcus Guardian (BCCH), Constantinos Ziogas (EMA), Valesca Retel (Netherlands Cancer Institute), Alexander Natz (EUCOPE) and many more.

*Participation by invitation only, contact info@euaac.org for inquiries.

Welcome by Jürgen Wasem

(University of Duisburg-Essen)  and Jörg Ruof (EAA Secretariat), with Petra Nies (G-BA)



Recording:

Maya Matthews

(Head of Unit at DG Santé, European Commission)

Presentation
Recording:

Niklas Hedberg

(Co-Chair at the Member State Coordination Group on HTA)

Abstract

Presentation
Recording:

Rui Santos Ivo

(Chair of Heads of HTA Agencies Group (HAG), President at INFARMED)

Presentation
Recording:

Welcome by Fabrizio Gianfrate

(University of Ferrara)  and Jörg Ruof (EAA Secretariat)



Recording:

Dirk Van den Steen

(Deputy Head of Unit at DG Santé, European Commission)

Recording:

Marco Marchetti

(Co-Chair at HTA Coordination Group)

Recording:

Robert Giovanni Nisticò  (President at AIFA)

Abstract
Recording:

Elias Pèan

(Head of Oncology and Radiopharmaceuticals, EMA)



Abstract

Recording:

Robin Doeswijk

(Head of European Affairs, EHA)



Abstract

Recording:

François Houÿez

(Director of Treatment Information and Access, EURORDIS)

Abstract

Recording:

Bernhard Wörmann

(Medical Superintendent at DGHO & Charité University Medicine)

Abstract

Recording:

Nathalie Largeron

(Global Head of HTA Strategy, Sanofi)



Abstract

Recording:

Panel Discussion

(E. Pèan, R. Doeswijk, F. Houÿez, B. Wörmann, N. Largeron, Video: M. Marchetti)



Recording:

Paolo Casali

(Director of Medical Oncology Istituto Nazionale Tumori, Milan & Council Member, ESMO



Presentation

Josie Godfrey (Director, JG

Zebra & former Lead of NICE Highly Specialised Technology Programme) & Alessandro Ciardiello (Consultant Ophthalmologist, Ospedale Parodi Delfino & Teacher, University of Tor Vergata)
Presentation

Maureen Rutten-van Mölken

(Head of HTA Department at ESHPM, Erasmus University)



Maya Matthews

(Head of Unit at DG Santé, European Commission)



Bernhard Wörmann

(Medical Superintendant at DGHO & Charité University Medicine)

Antonella Cardone

(CEO at Cancer Patients Europe)



Maiwenn Al

(HTA Department at ESHPM, Erasmus University)



Stefan Lange

(former Deputy Head at IQWiG)



Francesco Pignatti

(Scientific Advisor for Oncology at EMA)



Elisabeth de Vries

(Cancer Medicines Committee & MCBS Working Group at ESMO)

Laetitia Mariani

(HTA Collaborations Lead at Abbvie)



Panel Discussion

(B. Wörmann, A. Cardone, M. Al, S. Lange, F. Pignatti, E. de Vries, L. Mariani)

Carin Uyl-de Groot

(HTA Department at ESHPM, Erasmus University)



Michael Ermisch

(Head of Department AMNOG G-BA at GKV-SV)



Caroline Pothet

(Head of Advanced Therapies and Haematological Diseases at EMA)

Roisin Adams

(Chair of the HTA Coordination Group)



Elisabeth de Vries

(Cancer Medicines Committee & MCBS Working Group at ESMO)

César Hernández García

(Director General of Common NHS Portfolio and Pharmacy, Ministry of Health Spain)

Martin Kaiser

(European Hematology Association)



Bernhard Wörmann

(Medical Superintendant at German Society for Hematology and Oncology

 (DGHO))

Maya Matthews

(Head of Unit at DG Santé, European Commission)



Michael Berntgen

(Head of Scientific Evidence Generation Department, EMA)



Valentina Strammiello

(Director of Programmes, European Patients’ Forum)



Renato Bernardini

(Professor of Pharmacology, University of Catania School of Medicine & Deputy President, AIFA)

Rosa Giuliani

(Director of Public Policy at ESMO)



François Houÿez

(Director of Treatment Information and Access at EURORDIS)

Michael Berntgen

(Head of Scientific Evidence Generation Department, EMA)



Renato Bernardini

(Member & Dean, Board of Directors at AIFA)



Marc Van De Casteele

(Coordinator Assessment of Pharmaceuticals for Reimbursement at RIZIV-INAMI)

James Ryan

(Co-Lead, HTA Working Group Workstream on Methodology at EFPIA & Director, HTA Policy at AstraZeneca)

Ioana Siska

(Policy Officer, European Commission, DG Santé, Medical Devices and Health Technology Assessment Unit)

Antonella Cardone

(Patient Advocacy Expert at Pancreatic Cancer Europe)



Solange Peters

(Professor of Medical Oncology and President of ESMO)



Anja Schiel

(Lead Methodologist in Regulatory and Pharmacoeconomic Statistics NoMA)